Nuove linee guida ISPD per il trattamento della peritonite in dialisi peritoneale: cosa c'è di nuovo?

Fried L.F. , Bernardini J. , Johnston J.R. , Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176–82.

Woodrow G. , Turney J.H. , Brownjohn A.M. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17: 360–4.

Choi P. , Nemati E. , Banerjee A. , Preston E. , Levy J. , Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis 2004; 43: 103–11.

Bayston R. , Andrews M. , Rigg K. , Shelton A. Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1999; 19: 550–5.

Bunke C.M. , Brier M.E. , Golper T.A. Outcomes of single organism peritonitis in peritoneal dialysis: gram-negatives versus gram-positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52: 524–9.

Johnson D.W. , Dent H. , Hawley C.M. . Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 2009; 53: 290–7.

Levy J. , Brown E. , Daley C. , Lawrence A. Peritonite. Il Manuale Oxford - Dialisi, Edizione italiana a cura di Maurizio GallienkEdi. Ermes S.r.L, 2010; 342.

Li P.K. , Szeto C.C. , Piraino B. . Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393–423.

Lui S.L. , Cheng S.W. , Ng S.Y. . Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 2005; 68: 2375–80.

Coffin E. , Herbiet L. , Pouthier D. . Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis. Perit Dial Int 2004; 24: 433–9.

Lima R.C. , Barreira A. , Cardoso F.L. , Lima M.H. , Leite M. Jr. . Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int 2007; 27: 56–60.

Kobayashi K. , Nakamoto H. , Okada S. . Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2006; 22: 65–8.

Zelenitsky S. , Barns L. , Findaly I. . Analysis of micro-biological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36: 1009–13.

Blunden M. , Zeitilin D. , Ashman N. , Fan SL , Single U.K. centre experience on the treatment of PD peritonitis-antibiotic levels and outcomes. Nephrol Dial Transplant 2007; 22: 1714–19.

Chow K.M. , Szeto C.C. , Cheung K.K. . Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am Soc Nephrol 2006; 1: 768–73.

Szeto C.C. , Chow K.M. , Wong T.Y. . Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 2002; 13: 1040–5.

Szeto C.C. , Kwan B.C. , Chow K.M. . Recurrent and relapsing peritonitis: causative organisms and response to treatment. Am J Kidney Dis 2009; 54: 702–10.

Finkelstein E.S. , Jekel J. , Troidle L. , Gorban-Brennan N. , Finkelstein F.O. , Bia F.J. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39: 1278–86.

Dasgupta M.K. , Ward K. , Noble P.A. , Larabie M. , Costerton J.W. Development of bacterial biofilms on Silastic catheter materials in peritoneal dialysis fluid. Am J Kidney Dis 1994; 23: 709–16.

O'Shea S. , Hawley C.M. , Mc Donald S.P. . Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 2009; 10: 19.

Huen S.C. , Hall I. , Topal J. , Mahnensmith R.L. , Brewster U.C. , Abu-Alfa A.K. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis. Am J Kidney Dis 2000; 36: 1183–92.

Szeto C.C. , Chow K.M. , Kwan B.C. . Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2007; 2: 245–51.

Barraclough K. , Hawley C.M. , McDonald S.P. . Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant 2009; 24: 3834–9.

Siva B. , Hawley C.M. , McDonald S.P. . Psudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4: 957–64.

Szeto C.C. , Chow V.C. , Chow K.M. . Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 2006; 69: 1245–52.

Faber M.D. , Yee J. Diagnosis and management of enteric disease and abdominal catastrophe in peritoneal dialysis patients with peritonitis. Adv Chronic Kidney Dis 2006; 13: 271–9.

Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int 2009; 29(Suppl 2): S161–5.

Ghebremedhin B. , Bluemel A. , Neumann K.H. , Koenig B. , Koenig W. Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysissuccessfully treated with voriconazole. J Med Microbiol 2009; 58: 678–82.

Sedlacek M. , Cotter J.G. , Suriawinata A.A. . Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis 2008; 51: 302–6.

Fahim M. , Hawley C.M. , McDonald S.P. . Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment and outcomes in 435 cases. Am J Kidney Dis 2010; 55: 690–7.